Background: Alcohol and other drug use is associated with poor sleep quality and quantity, but there is limited qualitative research exploring substance users’ experiences of sleep and few psychosocial sleep interventions for them...
The purpose of the Appropriate Use of Drug Testing in Clinical Addiction Medicine is to provide guidance about the effective use of drug testing in the identification, diagnosis, treatment, and promotion of recovery for patients...
ABSTRACT
Objectives: The study examined sex differences in trend and clinical characteristics of cannabis use disorder (CUD) diagnosis involved hospitalizations among adult patients.
Methods: We analyzed hospitalization data from the 2007...
This article highlights the overburdened health system in West Virginia, including a shortage of behavioral treatment professionals.
Introduction: Dual disorders (DD) are defined as the co-occurrence of substance use disorders with other psychiatric disorders across the lifespan. DD represent a diagnostic dimension with clinical peculiarities and specific...
In Latin America, substance related disorders are highly prevalent and one of the treatment strategies is the Therapeutic Communities (TCs), however, in Latin America there is scarce data about this treatment...
One of our selection of hot topics on important issues which sometimes generate heated debate. Both as a treatment resource for the patient and a group needing support in their own right, families affected by substance use are, claimed a UK...
This research project on drug-treatment systems in prisons in Eastern and South-East Europe looks in detail into the situation of drug users among criminal justice populations and the corresponding health-care responses in nine countries in...
Inclusion Health is a framework for action that helps find ways of improving the health and well-being for socially excluded groups. These populations, who have in common adverse life experiences and risk factors, such as poverty and...
Seizing on the theory’s propaganda value, in 1997 the head of the US National Institute on Drug Abuse proclaimed, “Addiction Is a Brain Disease, and It Matters.” His contention has been hailed as a breakthrough or condemned as a...
